In the propensity-score-matched analysis, participants with current or previous GLP-1RA records were compared with matched participants who had no GLP-1RA record at the time of survey completion
Rogliani P, Matera MG, Calzetta L, Hanania NA, Page C, Rossi I, Andreadi A, Galli A, Coppola A, Cazzola M, Lauro D
H., Nielsen, P
These clinicians make independent clinical decisions, which means the platform cannot guarantee that any individual will receive a prescription
CJC 1295 and ipamorelin act on growth hormone pathways, whilst retatrutide is an investigational triple incretin receptor agonist studied for obesity
bilateral hypoglossal nerve stimulation (e.g., Genio Device) is considered investigational